APA
IRD

American Portfolios Advisors’s Opus Genetics IRD Stock Holding History

American Portfolios Advisors’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$13 – 3327
2020
Q4 		$13 Hold
2
– – ﹤0.01% 2971
2020
Q3 		$17 Hold
2
– – ﹤0.01% 2935
2020
Q2 		$23 Hold
2
– – ﹤0.01% 2831
2020
Q1 		$14 Hold
2
– – ﹤0.01% 2764
2019
Q4 		$15 Hold
2
– – ﹤0.01% 2834
2019
Q3 		$16 Hold
2
– – ﹤0.01% 2819
2019
Q2 		$41 Hold
2
– – ﹤0.01% 2711
2019
Q1 		$51 Hold
2
– – ﹤0.01% 2596
2018
Q4 		$93 Hold
2
– – ﹤0.01% 2370
2018
Q3 		$178 Hold
2
– – ﹤0.01% 2371
2018
Q2 		$141 Buy
+2
New +$176 ﹤0.01% 2349

Other funds holding IRD

ACM
Altium Capital Management New York $42M AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NPF
Norris Perne & French Grand Rapids, Michigan $1.71B AUM 30.87% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
RCM
Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Portfolios Advisors's IRD Position: Q1 2021 in Review

American Portfolios Advisors sold out of Opus Genetics (IRD) in Q1 2021, closing a stake of 2 shares — an estimated $13 sold.

American Portfolios Advisors first reported a position in IRD in Q2 2018 and held it in 11 quarters. The position peaked at $178 in Q3 2018. 27 funds tracked by Wall St. Rank hold IRD as of Q1 2021.

  • American Portfolios Advisors reported no remaining Opus Genetics position as of Q1 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 2 Opus Genetics shares in Q1 2021, an estimated $13.
  • American Portfolios Advisors first reported a position in Opus Genetics in Q2 2018 and held it in 11 quarters.
  • American Portfolios Advisors's Opus Genetics position peaked at $178 in Q3 2018.
  • 27 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.